FDA Inspection 1055316 — Alexander E. Drilon, M.D.
The FDA completed an inspection of Alexander E. Drilon, M.D. on May 17, 2018 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 17, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New York, NY (United States)
Additional details
Clinical Investigator (CI)